Correlation Between Vivos Therapeutics and Cytosorbents Crp

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Cytosorbents Crp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Cytosorbents Crp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Cytosorbents Crp, you can compare the effects of market volatilities on Vivos Therapeutics and Cytosorbents Crp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Cytosorbents Crp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Cytosorbents Crp.

Diversification Opportunities for Vivos Therapeutics and Cytosorbents Crp

-0.61

Correlation Coefficient

Vivos Therapeutics  Cytosorbents Crp

Excellent diversification

The 3 months correlation between Vivos and Cytosorbents is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Cytosorbents Crp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytosorbents Crp and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Cytosorbents Crp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytosorbents Crp has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Cytosorbents Crp go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Cytosorbents Crp

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 6.88 times more return on investment than Cytosorbents Crp. However, Vivos Therapeutics is 6.88 times more volatile than Cytosorbents Crp. It trades about 0.03 of its potential returns per unit of risk. Cytosorbents Crp is currently generating about 0.0 per unit of risk. If you would invest  3,750  in Vivos Therapeutics on October 10, 2024 and sell it today you would lose (3,315) from holding Vivos Therapeutics or give up 88.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Cytosorbents Crp

Vivos Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cytosorbents Crp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cytosorbents Crp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Cytosorbents Crp may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Vivos Therapeutics and Cytosorbents Crp

The main advantage of trading using opposite Vivos Therapeutics and Cytosorbents Crp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Cytosorbents Crp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will offset losses from the drop in Cytosorbents Crp's long position.

The idea behind Vivos Therapeutics and Cytosorbents Crp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.